Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
Agreement further expands Aptar Pharma’s leading position in nasal delivery solutions and addresses significant unmet needs of delivering drugs locally over extended periods
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
Agreement further expands Aptar Pharma’s leading respiratory portfolio
The low-profile, 2” Disc Top Lite closure offers lighter weight combined with premium customization options
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
Aptar Closures’ E-Disc Top securely protects against in-transit leakage while eliminating the need for liners and extra shipping preparation fees
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
New facility is part of Aptar Pharma’s global expansion program
Subscribe To Our Newsletter & Stay Updated
